Global Specialty Drug Distribution 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01243025

Publication Date:

January 4, 2024

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Specialty Drug Distribution market size was valued at US$ 261790 million in 2023. With growing demand in downstream market, the Specialty Drug Distribution is forecast to a readjusted size of US$ 543380 million by 2030 with a CAGR of 11.0% during review period.
The research report highlights the growth potential of the global Specialty Drug Distribution market. Specialty Drug Distribution are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Specialty Drug Distribution. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Specialty Drug Distribution market.
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers鈥� ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.
Key Features:
The report on Specialty Drug Distribution market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Specialty Drug Distribution market. It may include historical data, market segmentation by Type (e.g., Oncology, Rheumatoid Arthritis), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Specialty Drug Distribution market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Specialty Drug Distribution market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Specialty Drug Distribution industry. This include advancements in Specialty Drug Distribution technology, Specialty Drug Distribution new entrants, Specialty Drug Distribution new investment, and other innovations that are shaping the future of Specialty Drug Distribution.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Specialty Drug Distribution market. It includes factors influencing customer ' purchasing decisions, preferences for Specialty Drug Distribution product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Specialty Drug Distribution market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Specialty Drug Distribution market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Specialty Drug Distribution market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Specialty Drug Distribution industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Specialty Drug Distribution market.
麻豆原创 Segmentation:
Specialty Drug Distribution market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Segmentation by application
Hospital and Clinic
Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Specialty Drug Distribution 麻豆原创 Size 2019-2030
2.1.2 Specialty Drug Distribution 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Specialty Drug Distribution Segment by Type
2.2.1 Oncology
2.2.2 Rheumatoid Arthritis
2.2.3 Multiple Sclerosis
2.2.4 Hemophilia
2.2.5 Others
2.3 Specialty Drug Distribution 麻豆原创 Size by Type
2.3.1 Specialty Drug Distribution 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Specialty Drug Distribution 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Specialty Drug Distribution Segment by Application
2.4.1 Hospital and Clinic
2.4.2 Pharmacy
2.4.3 Others
2.5 Specialty Drug Distribution 麻豆原创 Size by Application
2.5.1 Specialty Drug Distribution 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Specialty Drug Distribution 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Specialty Drug Distribution 麻豆原创 Size by Player
3.1 Specialty Drug Distribution 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Specialty Drug Distribution Revenue by Players (2019-2024)
3.1.2 Global Specialty Drug Distribution Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Specialty Drug Distribution Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Specialty Drug Distribution by Regions
4.1 Specialty Drug Distribution 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Specialty Drug Distribution 麻豆原创 Size Growth (2019-2024)
4.3 APAC Specialty Drug Distribution 麻豆原创 Size Growth (2019-2024)
4.4 Europe Specialty Drug Distribution 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Specialty Drug Distribution 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Specialty Drug Distribution 麻豆原创 Size by Country (2019-2024)
5.2 Americas Specialty Drug Distribution 麻豆原创 Size by Type (2019-2024)
5.3 Americas Specialty Drug Distribution 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Specialty Drug Distribution 麻豆原创 Size by Region (2019-2024)
6.2 APAC Specialty Drug Distribution 麻豆原创 Size by Type (2019-2024)
6.3 APAC Specialty Drug Distribution 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Specialty Drug Distribution by Country (2019-2024)
7.2 Europe Specialty Drug Distribution 麻豆原创 Size by Type (2019-2024)
7.3 Europe Specialty Drug Distribution 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Specialty Drug Distribution by Region (2019-2024)
8.2 Middle East & Africa Specialty Drug Distribution 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Specialty Drug Distribution 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Specialty Drug Distribution 麻豆原创 Forecast
10.1 Global Specialty Drug Distribution Forecast by Regions (2025-2030)
10.1.1 Global Specialty Drug Distribution Forecast by Regions (2025-2030)
10.1.2 Americas Specialty Drug Distribution Forecast
10.1.3 APAC Specialty Drug Distribution Forecast
10.1.4 Europe Specialty Drug Distribution Forecast
10.1.5 Middle East & Africa Specialty Drug Distribution Forecast
10.2 Americas Specialty Drug Distribution Forecast by Country (2025-2030)
10.2.1 United States Specialty Drug Distribution 麻豆原创 Forecast
10.2.2 Canada Specialty Drug Distribution 麻豆原创 Forecast
10.2.3 Mexico Specialty Drug Distribution 麻豆原创 Forecast
10.2.4 Brazil Specialty Drug Distribution 麻豆原创 Forecast
10.3 APAC Specialty Drug Distribution Forecast by Region (2025-2030)
10.3.1 China Specialty Drug Distribution 麻豆原创 Forecast
10.3.2 Japan Specialty Drug Distribution 麻豆原创 Forecast
10.3.3 Korea Specialty Drug Distribution 麻豆原创 Forecast
10.3.4 Southeast Asia Specialty Drug Distribution 麻豆原创 Forecast
10.3.5 India Specialty Drug Distribution 麻豆原创 Forecast
10.3.6 Australia Specialty Drug Distribution 麻豆原创 Forecast
10.4 Europe Specialty Drug Distribution Forecast by Country (2025-2030)
10.4.1 Germany Specialty Drug Distribution 麻豆原创 Forecast
10.4.2 France Specialty Drug Distribution 麻豆原创 Forecast
10.4.3 UK Specialty Drug Distribution 麻豆原创 Forecast
10.4.4 Italy Specialty Drug Distribution 麻豆原创 Forecast
10.4.5 Russia Specialty Drug Distribution 麻豆原创 Forecast
10.5 Middle East & Africa Specialty Drug Distribution Forecast by Region (2025-2030)
10.5.1 Egypt Specialty Drug Distribution 麻豆原创 Forecast
10.5.2 South Africa Specialty Drug Distribution 麻豆原创 Forecast
10.5.3 Israel Specialty Drug Distribution 麻豆原创 Forecast
10.5.4 Turkey Specialty Drug Distribution 麻豆原创 Forecast
10.5.5 GCC Countries Specialty Drug Distribution 麻豆原创 Forecast
10.6 Global Specialty Drug Distribution Forecast by Type (2025-2030)
10.7 Global Specialty Drug Distribution Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 AmerisourceBergen
11.1.1 AmerisourceBergen Company Information
11.1.2 AmerisourceBergen Specialty Drug Distribution Product Offered
11.1.3 AmerisourceBergen Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 AmerisourceBergen Main Business Overview
11.1.5 AmerisourceBergen Latest Developments
11.2 Mckesson
11.2.1 Mckesson Company Information
11.2.2 Mckesson Specialty Drug Distribution Product Offered
11.2.3 Mckesson Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Mckesson Main Business Overview
11.2.5 Mckesson Latest Developments
11.3 Cardinal Health
11.3.1 Cardinal Health Company Information
11.3.2 Cardinal Health Specialty Drug Distribution Product Offered
11.3.3 Cardinal Health Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Cardinal Health Main Business Overview
11.3.5 Cardinal Health Latest Developments
11.4 Phoenix
11.4.1 Phoenix Company Information
11.4.2 Phoenix Specialty Drug Distribution Product Offered
11.4.3 Phoenix Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Phoenix Main Business Overview
11.4.5 Phoenix Latest Developments
11.5 Medipal Holdings
11.5.1 Medipal Holdings Company Information
11.5.2 Medipal Holdings Specialty Drug Distribution Product Offered
11.5.3 Medipal Holdings Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Medipal Holdings Main Business Overview
11.5.5 Medipal Holdings Latest Developments
11.6 Alliance Healthcare
11.6.1 Alliance Healthcare Company Information
11.6.2 Alliance Healthcare Specialty Drug Distribution Product Offered
11.6.3 Alliance Healthcare Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Alliance Healthcare Main Business Overview
11.6.5 Alliance Healthcare Latest Developments
11.7 Sinopharm
11.7.1 Sinopharm Company Information
11.7.2 Sinopharm Specialty Drug Distribution Product Offered
11.7.3 Sinopharm Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Sinopharm Main Business Overview
11.7.5 Sinopharm Latest Developments
11.8 Express Scripts
11.8.1 Express Scripts Company Information
11.8.2 Express Scripts Specialty Drug Distribution Product Offered
11.8.3 Express Scripts Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Express Scripts Main Business Overview
11.8.5 Express Scripts Latest Developments
11.9 Shanghai Pharma
11.9.1 Shanghai Pharma Company Information
11.9.2 Shanghai Pharma Specialty Drug Distribution Product Offered
11.9.3 Shanghai Pharma Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Shanghai Pharma Main Business Overview
11.9.5 Shanghai Pharma Latest Developments
11.10 Anda
11.10.1 Anda Company Information
11.10.2 Anda Specialty Drug Distribution Product Offered
11.10.3 Anda Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Anda Main Business Overview
11.10.5 Anda Latest Developments
11.11 Jointown
11.11.1 Jointown Company Information
11.11.2 Jointown Specialty Drug Distribution Product Offered
11.11.3 Jointown Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Jointown Main Business Overview
11.11.5 Jointown Latest Developments
11.12 Max Pharma
11.12.1 Max Pharma Company Information
11.12.2 Max Pharma Specialty Drug Distribution Product Offered
11.12.3 Max Pharma Specialty Drug Distribution Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Max Pharma Main Business Overview
11.12.5 Max Pharma Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.